[1] |
WANG Haodi, DENG Zhengming, WANG Gang, JIANG Zhiwei.
Disease burden in colorectal cancer attributed to fasting hyperglycemia in china from 1990 to 2021 and projections of future trends
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 61-67.
|
[2] |
CAO Le, MA Minmin, LI Wenmin, SHUI Mingming, JIANG Cheng.
Trend of mortality and disease burden of gastric cancer in China,2004—2021
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 68-73.
|
[3] |
XUAN Wenzhen, GONG Jianmin, LI Na.
Incidence,mortality,and disease burden of cervical cancer in China,1990—2021: trends over the past 30 years and future prediction
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 694-700.
|
[4] |
PAN Hongxin, CUI Wangfei, LYU Licheng, WANG Xinzheng, CAO Ling, ZHANG Yongzhen.
Analysis of the incidence and mortality of malignant tumors in tumor registration areas of Shanxi Province,2020
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 700-706.
|
[5] |
DONG Junling, YANG Hui, LI Na.
Trend of the incidence of gastric cancer in China,1992—2021
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 593-597.
|
[6] |
SU Lili, LAN Zhenyu, LIN Huizhe, YAN Fangna, CHEN Weilian, LIN Wei.
Effects of sarcopenia on prognosis of prostate cancer treatment: a Meta-analysis
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 487-493.
|
[7] |
SUN Xiaoxia, WANG Yuping, SI Meili, ZHU Jing, ZHONG Mei.
Trends of incidence and mortality and the age-period-cohort of cervical cancer in China,1990—2019
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 317-320.
|
[8] |
QIN Liming, ZHOU Zihan, CAO Ji, LI Qiulin, YU Jiahua, RONG Minhua, ZHAO Libin, MAI Yuejiao, GE Lianying, QIN Yuzhou, YU Hongping.
Epidemiological characteristics and disease burden analysis of gastric cancer in Guangxi,2011—2018
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 172-178.
|
[9] |
WANG Juwei, WANG Jing, MA Lijun, LI Zan .
Trends in the incidence and mortality of liver cancer in China based on the JoinPoint regression model,2000—2019
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 180-185.
|
[10] |
ZHOU Zihan, LI Qiulin, YU Jiahua, RONG Minhua, CAO Ji, GE Lianying, TANG Weizhong, YU Hongping.
Analysis of the epidemiological characteristics and disease burden of malignant tumors in Guangxi, 2019#br#
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(1): 67-.
|
[11] |
LI Qiulin, YU Jiahua, RONG Minhua, ZHOU Zihan, CAO Ji, GE Lianying, YU Hongping, LIU Liang .
Epidemiological characteristics and the trend of disease burden of leukemia in children aged 0-14 years in Guangxi cancer registry areas,2015-2019
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(3): 304-310.
|
[12] |
ZHOU Zihan, LI Qiulin, YU Jiahua, RONG Minhua, LIAN Jiawei, MAI Yuejiao, CAO Ji, GE Lianying, TANG Weizhong, YU Hongping.
Analysis of the epidemiological characteristics of malignant tumors and disease burden in Guangxi,2018
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(2): 181-199.
|
[13] |
WANG Xin, ZHANG Xiaopeng, LI Jiajia, SUN Feng, YANG Linsheng, ZHA Zhenqiu.
Analysis of the incidence trend of malignant tumors of digestive system in Hefei, 2011—2015
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(1): 38-44.
|
[14] |
ZHANG Xu, HUA Jing, FAN Kangqiong, SU Liangping, WANG Dingbin.
Analysis of the incidence and mortality of malignant tumors in the cancer registration areas of Hainan,2017
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(1): 45-51.
|
[15] |
ZHU Yunfang, XU Wen, XIAO Yize, WEN Hongmei, CHEN Yang, SHI Qingping, REN Siying, CHENG Huirong, ZHU Linfang.
Incidence and mortality of stomach cancer in registration areas of Yunnan in 2016 and its trends from 2012 to 2016
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(5): 515-520.
|